Literature DB >> 96140

Lower levels of thyrotropin-releasing hormone-degrading activity in human cord and in maternal sera than in the serum of euthyroid, nonpregnant adults.

J T Neary, C Nakamura, I J Davies, M Soodak, F Maloof.   

Abstract

Thyrotropin-releasing hormone (TRH)-degrading activity was investigated in human cord, maternal, and euthyroid adult sera by measuring (a) the rate of disappearance of TRH and (b) the rate of formation of degradation products. The rate of TRH degradation in cord and maternal sera was 25-33% of that in euthyroid adult serum. Concomitantly, in cord and maternal sera, the rate of formation of proline, a major TRH degradation product in serum, was one-quarter to one-third that in euthyroid adult sera. The differences were highly significant (P less than 0.001). The decreased levels of TRH-degrading activity in cord and maternal sera cannot be explained by (a) the presence of a dialyzable inhibitor, (b) the absence of an activator of TRH degradation, or (c) a reversal of the degradation process. There was no difference in the types of radioactive degradation products formed by cord, maternal, and euthyroid adult sera. The low level of TRH-degrading activity and its possible relationship to high thyrotropin-stimulating hormone levels in cord serum suggest that TRH-degrading activity may be a factor to consider in investigations of the perinatal pituitary-thyroid axis, but further studies are needed to determine the role of serum degradation of TRH in regulating physiological levels of TRH.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96140      PMCID: PMC371729          DOI: 10.1172/JCI109092

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Concentration and distribution of TRH and LRH in the human fetal brain.

Authors:  A J Winters; R L Eskay; J C Porter
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

2.  Total and free triiodothyronine and thyroxine in early infancy.

Authors:  J Abuid; A H Klein; T P Foley; P R Larsen
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

3.  Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling.

Authors:  K M Gautvik; A H Tashjian; I A Kourides; B D Weintraub; C T Graeber; F Maloof; K Suzuki; J E Zuckerman
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

4.  Thyrotropin releasing hormine (TRH): distribution in the brain, blood and urine of the rat.

Authors:  I M Jackson; S Reichlin
Journal:  Life Sci       Date:  1974-06-01       Impact factor: 5.037

5.  Distribution and concentration of TRH in the rat brain.

Authors:  C Oliver; R L Eskay; N Ben-Jonathan; J C Porter
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

6.  Thyrotropin releasing hormone: development of inactivation system during maturation of the rat.

Authors:  J T Neary; J D Kieffer; P Federico; H Mover; F Maloof; M Soodak
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

7.  Thyroxine-binding by sera of pregnant women, newborn infants, and women with spontaneous abortion.

Authors:  J T DOWLING; N FREINKEL; S H INGBAR
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

8.  Thyrotropin-releasing hormone: regional distribution in rat brain.

Authors:  A Winokur; R D Utiger
Journal:  Science       Date:  1974-07-19       Impact factor: 47.728

9.  Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule.

Authors:  E C Ridgway; B D Weintraub; J L Cevallos; M C Rack; F Maloof
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  A radioimmunoassay for measurement of 3,3',5'-triiodothyronine (reverse T3).

Authors:  I J Chopra
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

View more
  7 in total

Review 1.  Prenatal treatment with thyrotrophin releasing hormone to prevent neonatal respiratory distress.

Authors:  F de Zegher; B Spitz; H Devlieger
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

2.  The specificity of nephritogenic antibodies. V. Glomerular localization of anti-GP 330 and anti-GP 90 antibodies present in passive Heymann serum.

Authors:  W M Bagchus; P J Hoedemaeker; J F Slegers; W W Bakker
Journal:  Br J Exp Pathol       Date:  1988-12

Review 3.  Regulation of thyroid-stimulating hormone (TSH) secretion in the fetus and neonate.

Authors:  E Roti
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

Review 4.  Is all cyclo(His-Pro) derived from thyrotropin-releasing hormone?

Authors:  C Prasad; A Jayaraman; H J Robertson; J K Rao
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

5.  Passive Heymann nephritis in pre- and post-natal rats.

Authors:  J Challice; A Z Barabas; J Cornish; J W Bruce; R Lannigan
Journal:  Br J Exp Pathol       Date:  1986-12

6.  Response of plasma pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypoglycaemia in Chagas's disease.

Authors:  R G Long; R H Albuquerque; A Prata; A J Barnes; T E Adrian; N D Christofides; S R Bloom
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

Review 7.  The Effect of Thyrotropin-Releasing Hormone and Antithyroid Drugs on Fetal Thyroid Function.

Authors:  Nikolaos Vrachnis; Orestis Tsonis; Dionisios Vrachnis; Nikolaos Antonakopoulos; George Paltoglou; Stavroula Barbounaki; George Mastorakos; Minas Paschopoulos; Zoi Iliodromiti
Journal:  Children (Basel)       Date:  2021-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.